Department of Translational Medicine
741 – 750 of 8626
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Functional Analysis of Variants in Complement Factor I Identified in Age-Related Macular Degeneration and Atypical Hemolytic Uremic Syndrome
(
- Contribution to journal › Article
-
Mark
The Role of Psychological Factors and Vaccine Conspiracy Beliefs in Influenza Vaccine Hesitancy and Uptake among Jordanian Healthcare Workers during the COVID-19 Pandemic
(
- Contribution to journal › Article
-
Mark
Intra-Patient Evolution of HIV-2 Molecular Properties
(
- Contribution to journal › Article
-
Mark
THE IMPACT OF VARICOCELE REPAIR ON CONVENTIONAL SEMEN PARAMETERS IN INFERTILE MEN: A META-ANALYSIS USING PRE- AND POST-OPERATIVE DATA
(
- Contribution to journal › Published meeting abstract
-
Mark
EFFECT OF VARICOCELE REPAIR ON CONVENTIONAL SPERM PARAMETERS IN INFERTILE PATIENTS WITH CLINICAL VARICOCELE: A SYSTEMATIC REVIEW AND META-ANALYSIS
(
- Contribution to journal › Published meeting abstract
-
Mark
Reply to Joep J. de Jong and Ewan A. Gibb's Letter to the Editor re: Gottfrid Sjödahl, Johan Abrahamsson, Karin Holmsten, et al. Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes. Eur Urol. 2022;81:316-7. Neoadjuvant Chemotherapy Response in Muscle-invasive Bladder Cancer: Differences in Intrinsic Biology or Subtyping Nomenclature?
(
- Contribution to journal › Letter
-
Mark
Molecular pathology of the non-luminal Ba/Sq-like and Sc/NE-like classes of urothelial tumours : An integrated immunohistochemical analysis
(
- Contribution to journal › Article
-
Mark
Complement C4 copy number variation is linked to SSA/Ro and SSB/La autoantibodies in systemic inflammatory autoimmune diseases
(
- Contribution to journal › Article
-
Mark
Evaluation of the RSR 3 screen ICA™ and 2 screen ICA™ as screening assays for type 1 diabetes in Sweden
(
- Contribution to journal › Article
-
Mark
2021 Updated European Association of Urology Guidelines on the Use of Adjuvant Pembrolizumab for Renal Cell Carcinoma
(
- Contribution to journal › Article